Skip to content

Clinical trials

Withdrawn Myeloproliferative Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Withdrawn Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20081
20142
20181
20201
20212
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Alliance for Clinical Trials in Oncology1
Case Comprehensive Cancer Center1
City of Hope Medical Center1
Leland Metheny1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
Mayo Clinic1
University of California, San Francisco1
University of Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders12
Leukemia, Lymphocytic, Chronic, B-Cell7
Leukemia, Myeloid, Acute7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Lymphoma, Non-Hodgkin6
Myelodysplastic Syndromes6
Burkitt Lymphoma5
Leukemia, Myeloid, Accelerated Phase5
Leukemia, Myeloid, Chronic-Phase5
Leukemia, Myelomonocytic, Chronic5

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.